New Potomac Partners, LLC Abbott Laboratories Transaction History

New Potomac Partners, LLC

$192 Million
Q3 2024

A detailed history of New Potomac Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, New Potomac Partners, LLC holds 17,935 shares of ABT stock, worth $2.02 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

17,935

Previous 18,730 4.24%

Holding current value

$2.02 Million

Previous $1.95 Million 5.04%

% of portfolio

1.06%

Previous 1.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$100.07 - $118.13 $79,555 - $93,913	-795 Reduced 4.24%	17,935 $2.04 Million
Q2 2024 Jul 17, 2024	BUY	$100.73 - $112.44 $47,343 - $52,846	470 Added 2.57%	18,730 $1.95 Million
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $17,851 - $19,716	163 Added 0.9%	18,260 $2.08 Million
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $19,210 - $23,515	-213 Reduced 1.16%	18,097 $1.99 Million
Q3 2023 Oct 17, 2023	BUY	$95.53 - $114.62 $92,664 - $111,181	970 Added 5.59%	18,310 $1.77 Million
Q2 2023 Jul 21, 2023	BUY	$100.78 - $112.29 $12,899 - $14,373	128 Added 0.74%	17,340 $1.89 Million
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $5,133 - $6,042	-53 Reduced 0.31%	17,212 $1.74 Million
Q4 2022 Jan 18, 2023	SELL	$95.06 - $111.52 $329,382 - $386,416	-3,465 Reduced 16.71%	17,265 $0
Q3 2022 Oct 17, 2022	SELL	$96.76 - $112.03 $23,706 - $27,447	-245 Reduced 1.17%	20,730 $2.01 Million
Q2 2022 Jul 11, 2022	BUY	$102.07 - $123.37 $2,041 - $2,467	20 Added 0.1%	20,975 $2.28 Million
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $16,532 - $20,160	145 Added 0.7%	20,955 $2.48 Million
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $22,528 - $27,584	-195 Reduced 0.93%	20,810 $2.93 Million
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $27,998 - $30,974	240 Added 1.16%	21,005 $2.48 Million
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $2.2 Million - $2.59 Million	20,765 New	20,765 $2.41 Million
Q4 2020 Jan 28, 2021	SELL	$105.0 - $114.42 $47,250 - $51,489	-450 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $11,514 - $12,708	-200 Reduced 30.77%	450 $27,000
Q1 2018 Apr 18, 2018	SELL	$56.27 - $63.62 $2,813 - $3,181	-50 Reduced 7.14%	650 $39,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $37,576 - $40,229	700	700 $40,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Potomac Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Potomac Partners, LLC with notifications on news.

Account

New Potomac Partners, LLC Abbott Laboratories Transaction History